Published in Diabetes Care on July 01, 1998
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care (2010) 4.10
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest (2003) 2.95
Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care (2008) 2.80
Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax (2006) 2.46
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J (2013) 2.02
Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation (2014) 1.81
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol (2010) 1.48
Exercise therapy in type 2 diabetes: is daily exercise required to optimize glycemic control? Diabetes Care (2012) 1.40
Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectiveness. Diabetes Care (2013) 1.15
Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota. Am J Public Health (2001) 1.12
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care (2009) 1.09
Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors. Mayo Clin Proc (2010) 1.09
Prevalence of Type 2 diabetic patients within the targets of care guidelines in daily clinical practice: a multi-center study in Brazil. Rev Diabet Stud (2006) 1.06
Ficus deltoidea: A Potential Alternative Medicine for Diabetes Mellitus. Evid Based Complement Alternat Med (2012) 1.05
Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes. Diabetes Care (2013) 0.99
Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J (2012) 0.99
Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem (2009) 0.99
Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil. Diabetol Metab Syndr (2009) 0.98
Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women. Diabetes Care (2014) 0.95
Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes Dev Ctries (2010) 0.93
Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics (2007) 0.89
Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study. PLoS One (2012) 0.89
Parental longevity and diabetes risk in the Diabetes Prevention Program. J Gerontol A Biol Sci Med Sci (2011) 0.89
Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab (2011) 0.89
Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia. Mayo Clin Proc (2010) 0.89
Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. Am J Epidemiol (2010) 0.87
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes. Cardiovasc Diabetol (2004) 0.86
Hemoglobin A1c can be helpful in predicting progression to diabetes after Whipple procedure. HPB (Oxford) (2007) 0.86
Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes. Cardiovasc Diagn Ther (2014) 0.85
Diabetes in rural towns: effectiveness of continuing education and feedback for healthcare providers in altering diabetes outcomes at a population level: protocol for a cluster randomised controlled trial. Implement Sci (2013) 0.84
Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. Genes Nutr (2007) 0.84
Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study. Diabetes Care (2015) 0.84
Metabolic syndrome predicts long-term mortality in subjects without established diabetes mellitus in asymptomatic Korean population: A propensity score matching analysis from the Korea Initiatives on Coronary Artery Calcification (KOICA) registry. Medicine (Baltimore) (2016) 0.84
Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study. Cardiovasc Diabetol (2003) 0.83
Diabetes, insulin-mediated glucose metabolism and Sertoli/blood-testis barrier function. Tissue Barriers (2013) 0.83
Prognostic value of dobutamine stress echocardiography in diabetic patients. Int J Cardiovasc Imaging (2010) 0.82
Management of diabetes across the course of disease: minimizing obesity-associated complications. Diabetes Metab Syndr Obes (2011) 0.82
Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions. Cardiovasc Diabetol (2007) 0.79
How to define prehypertension in diabetes/metabolic syndrome. Diabetes Care (2009) 0.79
Insulin detemir for the treatment of obese patients with type 2 diabetes. Diabetes Metab Syndr Obes (2012) 0.79
Cardiovascular autonomic neuropathy in context of other complications of type 2 diabetes mellitus. Biomed Res Int (2013) 0.78
Treatment and impact of dyslipidemia in diabetic nephropathy. Clin Exp Nephrol (2013) 0.78
NMR-based prediction of cardiovascular risk in diabetes. Nat Med (2007) 0.77
Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study. Diabetes Care (2016) 0.77
Validation study to compare effects of processing protocols on measured N (ε)-(carboxymethyl)lysine and N (ε)-(carboxyethyl)lysine in blood. J Clin Biochem Nutr (2013) 0.77
Control of risk factors among people with diagnosed diabetes, by lower extremity disease status. Prev Chronic Dis (2009) 0.76
A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol. Can J Cardiol (2008) 0.76
Risk factors for cardiovascular disease in women with diabetes. Gend Med (2010) 0.76
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy. Endocr Rev (2017) 0.75
Detecting prediabetes among Hispanics/Latinos from diverse heritage groups: Does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos. Prev Med (2016) 0.75
Advances in diabetes for the millennium: the heart and diabetes. MedGenMed (2004) 0.75
The potential impact of family history of metabolic syndrome and risk of type 2 diabetes mellitus: In a highly endogamous population. Indian J Endocrinol Metab (2014) 0.75
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus. Vasc Health Risk Manag (2016) 0.75
Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications. J Diabetes Investig (2012) 0.75
Long-Term Clinical Outcomes in Diabetic Rhesus Macaques (Macaca mulatta) Treated with Medroxyprogesterone Acetate for Endometriosis. Comp Med (2016) 0.75
Effects of folic acid supplementation on serum homocysteine levels, lipid profiles, and vascular parameters in post-menopausal Korean women with type 2 diabetes mellitus. Nutr Res Pract (2017) 0.75
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
Community education for cardiovascular health. Lancet (1977) 6.32
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 5.87
Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol (1988) 4.20
Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation (1996) 4.10
Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care (1991) 3.51
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia (1991) 3.48
The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord (2001) 3.39
A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet (1997) 3.37
Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes (1992) 3.27
The homeostasis model in the San Antonio Heart Study. Diabetes Care (1997) 2.92
A simple language-based acculturation scale for Mexican Americans: validation and application to health care research. Am J Public Health (1985) 2.71
Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas. Genet Epidemiol (1986) 2.71
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia (1994) 2.60
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med (1999) 2.58
Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA (1998) 2.56
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet (1999) 2.42
A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care (1996) 2.35
Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA (1989) 2.26
Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol (1984) 2.16
The recent decline in ischemic heart disease mortality. Ann Intern Med (1979) 2.15
Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes (1990) 2.15
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes (1995) 2.09
Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med (1988) 2.06
Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol (1990) 2.03
Role of insulin in endogenous hypertriglyceridemia. J Clin Invest (1967) 2.00
A quantitative scale of acanthosis nigricans. Diabetes Care (1999) 1.99
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia (2009) 1.92
A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet (2001) 1.91
Affluence and cardiovascular risk factors in Mexican-Americans and other whites in three northern California communities. J Chronic Dis (1975) 1.89
Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care (2001) 1.88
Prevalence, detection, and control of hypertension in a biethnic community. The San Antonio Heart Study. Am J Epidemiol (1985) 1.85
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis (1986) 1.83
Special health problems of Mexican-Americans: obesity, gallbladder disease, diabetes mellitus, and cardiovascular disease. Adv Intern Med (1989) 1.82
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J (1996) 1.82
Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care (1989) 1.81
Prevalence of diabetes in Mexican Americans. Relationship to percent of gene pool derived from native American sources. Diabetes (1984) 1.80
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation (2000) 1.78
A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study. Am J Epidemiol (1986) 1.75
Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes (1988) 1.72
The distribution of plasma lipoproteins in middle-aged male runners. Metabolism (1976) 1.69
Decreased prevalence of hypertension in Mexican-Americans. Hypertension (1990) 1.66
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes (1997) 1.64
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int (2000) 1.62
Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev (1998) 1.62
Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol (1988) 1.61
Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev (1999) 1.61
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS) Am J Clin Nutr (1997) 1.59
Cardiovascular risk factors in Mexican Americans in Laredo, Texas. I. Prevalence of overweight and diabetes and distributions of serum lipids. Am J Epidemiol (1981) 1.59
Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol (1997) 1.56
Clinical gallbladder disease in NIDDM subjects. Relationship to duration of diabetes and severity of glycemia. Diabetes Care (1993) 1.56
Ethnic differences in health knowledge and behaviors related to the prevention and treatment of coronary heart disease. The San Antonio Heart Study. Am J Epidemiol (1983) 1.55
Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes (1996) 1.53
Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med (1986) 1.53
Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol (1997) 1.53
Is there an excess in maternal transmission of NIDDM? Diabetologia (1995) 1.50
Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia (1983) 1.48
Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care (1991) 1.45
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes (1998) 1.45
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects. Int J Obes Relat Metab Disord (1996) 1.43
Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism (1994) 1.42
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke (1996) 1.42
Death during jogging or running. A study of 18 cases. JAMA (1979) 1.40
Insulin delivery rate into plasma in normal and diabetic subjects. J Clin Invest (1968) 1.38
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol (1999) 1.37
Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med (1996) 1.36
Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes (1986) 1.35